Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H Powis

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2002
Typing alleles of TAP1 and TAP2Stephen H Powis
Nephron. Clinical Practice|December 3, 2003
Halting chronic allograft nephropathy--do we already have the drugs?Stephen H Powis
Advances in Biological Regulation|October 14, 2022
COVID-19 models and expectations - Learning from the pandemicJohn P A Ioannidis, Stephen H Powis
Nephron. Clinical Practice|October 22, 2008
Introducing 'nephron clinical guidelines'John Cunningham, John Connolly, Stephen H Powis, et al.
Transplantation|June 28, 2003
Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic isletsStephen J Hughes, Susan E Davies, Stephen H Powis, et al.
Kidney International|December 1, 2005
Nuclear receptors and their coregulators in kidneyXiong Z Ruan, Zac Varghese, Stephen H Powis, et al.
American Journal of Physiology. Renal Physiology|March 17, 2005
Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allograftsZac Varghese, Ray Fernando, John F Moorhead, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 27, 2007
Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cellsKun L Ma, Xiong Z Ruan, Stephen H Powis, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2003
PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathwayXiong Z Ruan, John F Moorhead, Ray Fernando, et al.
Transplantation|November 9, 2007
Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemiaKun L Ma, Xiong Z Ruan, Stephen H Powis, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2002
Typing alleles of TAP1 and TAP2Stephen H Powis
Nephron. Clinical Practice|December 3, 2003
Halting chronic allograft nephropathy--do we already have the drugs?Stephen H Powis
Advances in Biological Regulation|October 14, 2022
COVID-19 models and expectations - Learning from the pandemicJohn P A Ioannidis, Stephen H Powis
Nephron. Clinical Practice|October 22, 2008
Introducing 'nephron clinical guidelines'John Cunningham, John Connolly, Stephen H Powis, et al.
Transplantation|June 28, 2003
Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic isletsStephen J Hughes, Susan E Davies, Stephen H Powis, et al.
Kidney International|December 1, 2005
Nuclear receptors and their coregulators in kidneyXiong Z Ruan, Zac Varghese, Stephen H Powis, et al.
American Journal of Physiology. Renal Physiology|March 17, 2005
Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allograftsZac Varghese, Ray Fernando, John F Moorhead, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 27, 2007
Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cellsKun L Ma, Xiong Z Ruan, Stephen H Powis, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2003
PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathwayXiong Z Ruan, John F Moorhead, Ray Fernando, et al.
Transplantation|November 9, 2007
Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemiaKun L Ma, Xiong Z Ruan, Stephen H Powis, et al.
Pageof 3